Cornell study maps how puppy antibodies neutralize canine parvovirus

A Cornell-led team published findings on Feb. 14, 2023, showing that puppies produce a surprisingly narrow antibody response that blocks canine parvovirus — a disease that began spreading in 1978 and killed hundreds of thousands of dogs.

Close-up portrait of a healthy young puppy on a veterinary examination table in soft natural light

Canine parvovirus researchers published a study on Feb. 14, 2023, that maps how puppy antibodies bind to and neutralize canine parvovirus, advancing understanding of a disease that began infecting dogs in Europe in 1978 and killed hundreds of thousands of dogs, mostly puppies. Canine parvovirus emerged suddenly in the late 1970s and rapidly spread worldwide, leading to severe outbreaks that killed thousands of dogs and likely infected millions more before effective vaccines were widely available.

The work links current laboratory findings to a long institutional history at Cornell’s Baker Institute for Animal Health and to collaborators at the University of Minnesota. Colin Parrish, interim director of the Baker Institute for Animal Health, said the study updates that legacy while clarifying why some vaccines can fail when given too early to very young animals, a period when puppies are particularly vulnerable.

Parrish described the original arrival of a vaccine as a pivotal moment. “It was really at the time a worldwide relief, a miracle,” he said. Vaccination remains essential for dog owners, who should ensure that their pets receive the full recommended vaccination series and regular boosters to protect against the virus.

The paper, led from Cornell in collaboration with University of Minnesota scientists, demonstrates that puppies produce a narrow antibody response to the virus: rather than dozens of distinct antibodies, the immune reaction is dominated by just two or three that block the virus’s receptor-binding site, Parrish said. “Immunologists or veterinarians would likely guess that there must be dozens or hundreds of different antibodies, but instead this work shows there are really only two or three,” he said. This limited response helps clarify the challenges faced by young puppies, who receive maternal antibodies that can neutralize vaccine virus, rendering early vaccinations ineffective.

The study team included researchers listed in the report from Cornell and Minnesota: doctoral student Oluwafemi Adu and postdoctoral researcher Marta V. Schoenle at the Baker Institute, assistant research professor Hyunwook Lee and research collaborator Susan Hafenstein at the University of Minnesota, co-author Simon Früh, age 21, and other contributors including Wendy S. Weichert and Andrew I. Flyak.

Those findings arrive against the Baker Institute’s own milestone: “This is an update on a very old story for us and for the institute, which is celebrating its 75th anniversary this year,” Parrish said, tying the new structural work to decades of institutional research into canine disease and vaccine development. The emergence of canine parvovirus and its devastating impact on populations underscores the continuing importance of this research.

The study builds on the institute’s historical involvement with canine parvovirus and on collaborative work with Minnesota researchers; additional context and coverage of the research appear on Cornell University News and related publications.

Researchers say the structural picture of how host antibodies neutralize the virus offers a clearer framework for thinking about vaccine design and for understanding why some puppies remain vulnerable despite current preventive measures. Dogs with canine parvovirus typically develop lethargy, depression, loss of appetite, fever, vomiting, and severe bloody diarrhea, accompanied by dehydration and severe pain—symptoms that underscore the seriousness of the infection. The paper’s authors include a mix of senior scientists, early-career researchers, and students who contributed laboratory and analytical work to produce the molecular snapshots described in the report.

The study’s publication date, Feb. 14, 2023, marks the latest contribution from the Baker Institute to decades of canine vaccine science and to continuing collaboration between Cornell and Minnesota research teams. Canine Parvovirus: Prevention and Treatment Options offers insights on what steps can dog owners take to protect their pets from canine parvovirus.

Source

Original reporting: view the original article.

Comments are closed.